首页> 外文OA文献 >Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C and hepatitis B:Results from the Global Burden of Disease GBD 2013 study
【2h】

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C and hepatitis B:Results from the Global Burden of Disease GBD 2013 study

机译:估计由注射毒品引起的疾病负担是艾滋病毒,丙型肝炎和乙型肝炎的危险因素:GBD 2013全球疾病负担研究结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Previous estimates of the burden of HIV, hepatitis B (HBV) and hepatitis C (HCV) among people who inject drugs have not included estimates of the burden attributable to the consequences of past injecting. We provided these estimates in the Global Burden of Disease (GBD) 2013 study. Methods: We modelled HBV and HCV burden (including cirrhosis and liver cancer burden) and HIV at the country, regional, and global level. We extracted data on the proportion of notified HIV cases by transmission route and estimated the contribution of IDU to HBV and HCV disease burden using a cohort method that injecting drug use (IDU) to HBV and HCV disease burden using a cohort method that recalibrated individuals’ history of IDU, and accumulated risk of HBV and HCV due to IDU. We estimated data on current IDU from a meta-analysis of HBV and HCV incidence among injectors; and country-level data on the incidence of HBV and HCV between 1990 and 2013. We calculated estimates of burden of disease through three metrics: years of life lost (YLL), years of life lived with disability (YLD), deaths, and disability-adjusted life-years (DALYs).Findings: In 2013, an estimated 10.08 million DALYs were attributable to previous exposure to HIV, HBV and HCV via IDU, a four-fold increase since 1990. In 2013, IDU was estimated to cause 4.0% (2.82 million DALYs (95% uncertainty interval (95%UI) 2.4-3.8 million DALYs), 1.1% (216,000; 101,000-338,000) and 39.1% (7.05 million; 5.88-8.15 million) of total DALYs due to HIV, HBV and HCV, respectively. IDU-attributable HCV burden was 2.5 times that for HIV. IDU-attributable HIV burden was highest in low- to middle-income countries, and IDU-attributable HCV burden highest in high-income countries.Conclusions: IDU is a major contributor to GBD. There is a need to scale up efficacious interventions to prevent and treat these important causes of health burden.
机译:背景:先前对注射毒品者中HIV,乙型肝炎(HBV)和丙型肝炎(HCV)负担的估计未包括对过去注射的后果造成的负担的估计。我们在2013年全球疾病负担(GBD)研究中提供了这些估算值。方法:我们在国家,地区和全球范围内对HBV和HCV负担(包括肝硬化和肝癌负担)和HIV进行建模。我们通过传播途径提取了报告的HIV病例比例的数据,并使用队列方法重新评估了个体的分布,并使用队列研究方法(将药物使用(IDU)注射到HBV和HCV疾病负担中),估计了IDU对HBV和HCV疾病负担的贡献。 IDU病史,以及因IDU引起的HBV和HCV累积风险。我们通过对喷油器中HBV和HCV发生率的荟萃分析来估算当前IDU的数据。以及1990年至2013年之间的HBV和HCV发病率的国家级数据。我们通过以下三个指标计算了疾病负担的估算值:丧失生命的年限(YLL),有残疾的生命年限(YLD),死亡和残疾调整后的生命年(DALYs)。发现:2013年,估计有1,008万个DALY与先前通过IDU暴露于HIV,HBV和HCV的接触有关,是1990年以来的四倍。2013年,IDU估计导致4.0 (%)(282万DALYs(95%不确定区间(95%UI)2.4-380万DALYs),1.1%(216,000; 101,000-338,000)和39.1%(705万; 5.88-8.15百万),分别为HBV和HCV,IDU引起的HCV负担是HIV的2.5倍,IDU引起的HIV负担在中低收入国家最高,IDU归因的HCV负担在高收入国家最高。是GBD的主要贡献者,因此有必要扩大有效干预措施,以预防和治疗这些疾病造成健康负担的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号